This trial is active, not recruiting.

Condition erectile dysfunction
Treatment far infrared radiation
Phase phase 1
Sponsor GAAD Medical Research Institute Inc.
Start date August 2007
End date February 2009
Trial size 3 participants
Trial identifier NCT00573209, GAAD-EDS-CTP1


A preliminary study to determine the possibility of using far infrared (FIR) radiation to treat impotency.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation non-randomized
Endpoint classification efficacy study
Intervention model single group assignment
Masking open label
Primary purpose treatment
far infrared radiation
Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each session.

Primary Outcomes

The primary end point is to determine the therapeutic effects of far infrared radiation on erectile dysfunction.
time frame: 1 year

Secondary Outcomes

The effect of far infrared radiation on other male conditions like prostate cancer
time frame: 1 year

Eligibility Criteria

Male participants of any age.

Inclusion Criteria: - Persons with erection challenges Exclusion Criteria: - None

Additional Information

Official title Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction.
Description Erectile dysfunction is characterized by the regular or repeated inability to obtain or maintain an erection. Erection depends on a complex interaction of psychological, neural, vascular and endocrine factors. We are proposing a non-drug and a non-invasive radiation treatment for the enhancement of erection.
Trial information was received from ClinicalTrials.gov and was last updated in August 2009.
Information provided to ClinicalTrials.gov by GAAD Medical Research Institute Inc..